Article Information
History
- August 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- ME Jansen1,2,*,
- T Rigter1,2,
- TMC Fleur1,3,
- PC Souverein3,
- WMM Verschuren4,7,
- SJ Vijverberg3,5,
- JJ Swen6,
- W Rodenburg2 and
- MC Cornel1
- 1Section Community Genetics, Department of Clinical Genetics and Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- 2Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
- 3Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
- 4Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
- 5Department of Respiratory Medicine, Amsterdam Public Health Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- 6Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands
- 7Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
- ↵*Corresponding author
M.E. Jansen, PhD, Centre for Health Protection, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. T +31 30 274 3869 | marleen.jansen{at}rivm.nl
Posted August 30, 2022.
Predictive value of SLCO1B1 c.521T>C polymorphism on observed changes in the treatment of 1136 statin-users
